Antibe Therapeutics Inc(Pre-Merger) ATBPF

No Rush to Pickup ATE Shares, Tax Loss Selling Coming

[davgro]

As I said in my previous post, investors are waiting until closer to calendar Q1 2024 to accumulate ATE shares as there will be no significant news until then. 

There has been no stock price appreciation since the announcement of Health Canada's approval to initiate the PK/PD study.  In fact, weak hands are selling stock into the bid probably anticipating that they can repurchase them cheaper later in 2023.

As Duster posted on September 19th; "maybe it will re-test it's 52 week low of 41 cents."

[TriumphSpitSix]

100%. ATE has been a dog all year and will dump into year end tax loss season.

[Benedictus]

The general markets are weak and as you say, it's currently risk off especially for illiquid micro caps. The Antibe weekly chart has remained predictable for well over a year and a half. The upper Bollinger gets tagged and many months later, expect the lower Bollinger to be tagged. Bollingers have formed a rather narrow envelope suggesting a strong likelihood that .42 gets tagged or pierced in